← All trials
NCT05342558
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 19, 2017
- Primary completion
- Nov 19, 2020
- Completion date
- Feb 1, 2021
- First posted
- Apr 22, 2022
- Last posted
- Apr 22, 2022
- Enrollment
- 133
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Government of MexicoLead sponsor
- Government of MexicoReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.